Therapies for Cognitive Deficits Associated with Chemotherapy for Breast Cancer: A Systematic Review of Objective Outcomes

Archives of Physical Medicine and Rehabilitation

Volumn 96, Issue 10, 2015, Pages 1880-1897

  Morean, Diane F ^a,b   O'Dwyer, Linda ^b   Cherney, Leora R ^a,b  

^a REHABILITATION INSTITUTE OF CHICAGO   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Attention; Breast neoplasms; Cognition; Drug therapy; Mental processes; Psychological tests; Rehabilitation

Indexed keywords

ATTENTION; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER STAGING; COGNITION; COGNITIVE DEFECT; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL (TOPIC); DAILY LIFE ACTIVITY; DISEASE ASSOCIATION; EXECUTIVE FUNCTION; FEMALE; HUMAN; KINESIOTHERAPY; NEUROPSYCHOLOGICAL TEST; PATIENT COMPLIANCE; PHARMACEUTICAL CARE; QUALITY CONTROL; QUANTITATIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SELF CARE; SELF ESTEEM; SOCIAL INTERACTION; SYSTEMATIC REVIEW; VERBAL MEMORY; WORKING MEMORY; BREAST NEOPLASMS; CHEMICALLY INDUCED; COGNITION DISORDERS;

ANTINEOPLASTIC AGENT;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; COGNITION DISORDERS; FEMALE; HUMANS;

EID: 84943815397     PISSN: 00039993     EISSN: 1532821X     Source Type: Journal    
DOI: 10.1016/j.apmr.2015.05.012     Document Type: Review

References (25)

1. American Cancer Society. Global cancer facts and figures. 2nd ed. Available at: http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-027766.pdf. Accessed February 25, 2014.
2. American Cancer Society. What are the key statistics about breast cancer? January 31, 2014. Available at: http://www.cancer.org/cancer/breastcancer/detailedguide/breast-cancer-key-statistics. Accessed February 25, 2014.
3. H.S. Jim, K.M. Phillips, S. Chait, and et al. Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy J Clin Oncol 30 2012 3578 3587
4. J.S. Wefel, A.K. Saleeba, A.U. Buzdar, and C.A. Meyers Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer Cancer 116 2010 3348 3356
5. J.S. Wefel, and S.B. Schagen Chemotherapy-related cognitive dysfunction Curr Neurol Neurosci Rep 12 2012 267 275
6. B. Cimprich Development of an intervention to restore attention in cancer patients Cancer Nurs 16 1993 83 92
7. F. Munir, K. Kalawsky, C. Lawrence, J. Yarker, C. Haslam, and S. Ahmed Cognitive intervention for breast cancer patients undergoing adjuvant chemotherapy: a needs analysis Cancer Nurs 34 2011 385 392
8. J.P. Higgins, and S. Green Cochrane handbook for systematic reviews of interventions, version 5.1.0 [updated March 2011] 2011 The Cochrane Collaboration Oxford Available at: www.cochrane-handbook.org Accessed June 25, 2014
9. C. Sherrington, R.D. Herbert, C.G. Maher, and A.M. Moseley PEDro. A database of randomized trials and systematic reviews in physiotherapy Man Ther 5 2000 223 226
10. R.E. Gearing, N. El-Bassel, A. Ghesquiere, S. Baldwin, J. Gillies, and E. Ngeow Major ingredients of fidelity: a review and scientific guide to improving quality of intervention research implementation Clin Psychol Rev 31 2011 79 88
11. C.G. Maher, C. Sherrington, R.D. Herbert, A.M. Mosely, and M. Elkins Reliability of the PEDro scale for rating quality of randomized controlled trials Phys Ther 83 2003 713 721
12. F.T. Baumann, N. Drosselmeyer, A. Knicker, and et al. [Effects of a 3-month resistance training intervention on the cognitive abilities of breast cancer patients during chemotherapy] [German] Deutsche Zeitschrift für Onkologie 41 2009 70 75
13. D. Moher, A. Liberati, J. Tetzlaff, D.G. Altman PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement PLoS Med 6 2009 e1000097
14. M.M. Cherrier, K. Anderson, D. David, and et al. A randomized trial of cognitive rehabilitation in cancer survivors Life Sci 93 2013 617 622
15. J.A. O'Shaughnessy Effects of epoetin alfa on cognitive function, mood, asthenia, and quality of life in women with breast cancer undergoing adjuvant chemotherapy Clin Breast Cancer 23 Suppl 3 2002 S116 S120
16. J.A. O'Shaughnessy, S.J. Vukelja, F.A. Holmes, and et al. Feasibility of quantifying the effects of epoetin alfa therapy on cognitive function in women with breast cancer undergoing adjuvant or neoadjuvant chemotherapy Clin Breast Cancer 5 2005 439 446
17. S. Kesler, S.M. Hadi Hosseini, C. Heckler, and et al. Cognitive training for improving executive function in chemotherapy-treated breast cancer survivors Clin Breast Cancer 13 2013 299 306
18. L.M. Ercoli, S.A. Castellon, A.M. Hunter, and et al. Assessment of the feasibility of a rehabilitation intervention program for breast cancer survivors with cognitive complaints Brain Imaging Behav 7 2013 543 553
19. R.J. Ferguson, T.A. Ahles, A.J. Saykin, and et al. Cognitive-behavioral management of chemotherapy-related cognitive change Psychooncology 16 2007 772 777
20. R.J. Ferguson, B.C. McDonald, M.A. Rocque, and et al. Development of CBT for chemotherapy-related cognitive change: results of a waitlist control trial Psychooncology 21 2012 176 186
21. K. Milbury, A. Chaoul, K. Biegler, and et al. Tibetan sound meditation for cognitive dysfunction: results of a randomized controlled pilot trial Psychooncology 22 2013 2354 2363
22. D.L. Barton, K. Burger, P.J. Novotny, and et al. The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9 Support Care Cancer 21 2013 1185 1192
23. M. Poppelreuter, J. Weis, and H.H. Bartsch Effects of specific neuropsychological training programs for breast cancer patients after adjuvant chemotherapy J Psychosoc Oncol 27 2009 274 296
24. H.G. Mar Fan, M. Clemons, W. Xu, and et al. A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer Support Care Cancer 16 2008 577 583
25. H.G. Mar Fan, A. Park, W. Xu, and et al. The influence of erythropoietin on cognitive function in women following chemotherapy for breast cancer Psychooncology 18 2009 156 161